SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve approval of Unaudited financial ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Saturday, 8th November 2025 at its registered office in Hyderabad. The key agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended 30th September 2025 (i.e., Q2 and H1 FY26). The filing has been made under Regulation 29 of SEBI's LODR Regulations. The company's trading window for insiders has been closed from 1st October 2025 and will reopen on 11th November 2025.
This is a routine regulatory intimation ahead of the quarterly results announcement. Investors should watch the results on or after 8th November for actual revenue, profit, and margin numbers, which could move the stock. No material event or decision is being announced at this stage.